COJOCARU S, RUSSU I, BUTA G, BERSAN S, POTÎNG-RAȘCOV V, CULIUC N, BABA L. A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. OH&RM [Internet]. 2023Sep.29 [cited 2024Nov.23];4(4):19-6. Available from: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/374